Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK, NYKØBING F. ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.1% 1.5% 1.3% 1.2% 1.4% 1.3% 9.5% 9.3%   Credit score (0-100)   85 77 81 80 77 78 26 27   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   105.1 7.6 54.5 88.0 31.3 69.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,562 5,422 5,030 5,251 6,427 6,049 0.0 0.0   EBITDA   939 1,087 946 1,324 1,324 1,328 0.0 0.0   EBIT   644 638 718 965 1,056 1,075 0.0 0.0   Pre-tax profit (PTP)   661.3 657.7 734.3 984.4 1,121.2 1,173.4 0.0 0.0   Net earnings   513.1 501.9 581.8 765.3 874.2 914.7 0.0 0.0   Pre-tax profit without non-rec. items   661 658 734 984 1,121 1,173 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,367 932 1,337 1,017 796 666 0.0 0.0   Shareholders equity total   1,906 1,007 1,589 2,355 3,229 4,144 4,019 4,019   Interest-bearing liabilities   218 202 348 86.5 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,788 1,817 2,723 3,015 3,720 4,778 4,019 4,019   Net Debt   1.0 -193 32.4 -414 -420 -771 -4,019 -4,019     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,562 5,422 5,030 5,251 6,427 6,049 0.0 0.0   Gross profit growth   -2.3% -2.5% -7.2% 4.4% 22.4% -5.9% -100.0% 0.0%   Employees   7 7 7 7 7 7 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,788 1,817 2,723 3,015 3,720 4,778 4,019 4,019   Balance sheet change%   -5.9% -34.8% 49.8% 10.7% 23.4% 28.4% -15.9% 0.0%   Added value   939.2 1,086.9 946.2 1,324.0 1,414.8 1,328.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   258 -884 177 -680 -489 -383 -666 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.6% 11.8% 14.3% 18.4% 16.4% 17.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   24.0% 29.0% 32.8% 34.7% 33.6% 27.7% 0.0% 0.0%   ROI %   32.2% 39.7% 46.8% 44.9% 39.6% 31.8% 0.0% 0.0%   ROE %   25.4% 34.5% 44.8% 38.8% 31.3% 24.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   68.4% 55.4% 58.4% 78.1% 86.8% 86.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.1% -17.7% 3.4% -31.3% -31.7% -58.0% 0.0% 0.0%   Gearing %   11.4% 20.1% 21.9% 3.7% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   26.5% 4.9% 4.1% 5.1% 21.5% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.2 1.4 1.4 3.6 6.1 6.5 0.0 0.0   Current Ratio   2.2 1.4 1.4 3.6 6.1 6.5 0.0 0.0   Cash and cash equivalent   216.9 394.7 316.1 500.7 419.8 770.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   768.5 245.5 404.8 1,433.4 2,436.4 3,472.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   134 155 135 189 202 190 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   134 155 135 189 189 190 0 0   EBIT / employee   92 91 103 138 151 154 0 0   Net earnings / employee   73 72 83 109 125 131 0 0